ABI
AKRX

Adamant Biomedical Investments’s Akorn Inc AKRX Stock Holding History

Adamant Biomedical Investments’s Portfolio AKRX Stock Details AKRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$5.79M Buy
160,000
+100,000
+167% +$3.86M 1.38% 23
2014
Q3 		$2.18M Buy
+60,000
New +$2.15M 0.54% 56

Other funds holding AKRX

CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Adamant Biomedical Investments's AKRX Position: Q4 2014 in Review

Adamant Biomedical Investments increased its Akorn Inc (AKRX) stake by 167% in Q4 2014, buying an estimated $3.86M and bringing the position to 160,000 shares worth $5.79M. The position accounts for 1.38% of the portfolio, ranked #23.

Adamant Biomedical Investments first reported a position in AKRX in Q3 2014 and has held it in 2 quarters since. 265 funds tracked by Wall St. Rank hold AKRX as of Q4 2014.

  • Adamant Biomedical Investments held 160,000 shares of Akorn Inc worth $5.79M as of Q4 2014.
  • Adamant Biomedical Investments bought 100,000 Akorn Inc shares in Q4 2014, an estimated $3.86M.
  • Akorn Inc made up 1.38% of Adamant Biomedical Investments's portfolio in Q4 2014, its #23 holding.
  • Adamant Biomedical Investments first reported a position in Akorn Inc in Q3 2014 and has held it in 2 quarters since.
  • 265 funds tracked by Wall St. Rank held Akorn Inc as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.